Biomarkers Journal Open Access

  • ISSN: 2472-1646
  • Journal h-index: 9
  • Journal CiteScore: 1.05
  • Journal Impact Factor: 0.69
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Commentary Article - (2022) Volume 8, Issue 7

Biomarkers are Measurable and No Longer Outline how a Man or Woman Feels or Functions
Anubhav Tripathi*
Department of Biomedical Engineering, Brown University, Japan
*Correspondence: Anubhav Tripathi, Department of Biomedical Engineering, Brown University, Japan, Email:

Received: 29-Jun-2022, Manuscript No. IPBM-22-14524; Editor assigned: 01-Jul-2022, Pre QC No. IPBM-22-14524 (PQ); Reviewed: 15-Jul-2022, QC No. IPBM-22-14524; Revised: 20-Jul-2022, Manuscript No. IPBM-22-14524 (R); Published: 27-Jul-2022, DOI: 10.35841/2472-1646.22.8.145


They must be non-invasive, without problems measured, inexpensive, and convey fast results. The time period biomarker or biological marker, refers to a large variety of measures which seize what’s going on in a mobileular or organism at a given moment. Biomarkers are goal clinical symptoms and symptoms (rather than signs mentioned through the patient) used to degree the presence or development of disorder, or the outcomes of remedy. Biomarkers may have molecular, histologic, radiographic or physiological characteristics. Examples of biomarkers consist of the whole lot from blood stress and coronary heart price to basic metabolic research and X-ray findings to complicated histologic and genetic checks of blood and different tissues. Biomarkers are measurable and do now no longer outline how a man or woman feels or functions. Although the time period biomarker is extraordinarily new, clinical symptoms and symptoms were utilized in medical exercise for centuries. Many biomarkers, inclusive of coronary heart price, urinalysis and blood lead levels, are typically used and well-researched. Within the upward thrust of genomics and different advances in molecular biology, new biomarker research have entered a promising generation with capability for early prognosis and effective, personalised remedy of many diseases. In medical trials, biomarkers can function intermediate markers of a disorder and assist decide if a particular remedy is efficaciously treating that disorder. The extra conventional technique of the usage of endpoints like first-rate of existence or mortality in medical research could make accruing sufficient information each time and fee prohibitive. Qualified biomarkers have the capability to offer treasured statistics that could reduce uncertainty in regulatory choices for the duration of drug improvement. When a biomarker is qualified, it manner that it has passed through a proper regulatory manner to make sure that we will rely upon it to have a particular interpretation and application in clinical product improvement and regulatory review, in the said context of use. It is crucial to observe that a biomarker is qualified, and now no longer the biomarker size method. The qualification manner is collaborative, in which the Biomarker Qualification Program works with the requestor(s) in guiding biomarker improvement. Multiple involved events regularly paintings together in running corporations or consortia to expand a biomarker for qualification. This technique lets in for shared resources, and decreases burden on individual collaborators. In turn, this will inspire involved events to sign up for a DDT improvement attempt notwithstanding restricted resources. The standards of biomarkers in disorder were carried out to the detection, screening, prognosis, remedy and tracking of most cancers. Traditionally, anti-most cancers tablets had been marketers that killed each most cancers cells and healthful cells. However, extra cantered treatments have now been evolved that may be directed to kill most cancers cells only, even as sparing healthful cells. The evaluation of an average biomarker in most cancers facilitates in the improvement of treatments that may goal the biomarker.


This can decrease the threat of toxicity and decrease the fee of remedy. In most cancers research, genetic research is treasured due to the fact genetic abnormalities so regularly underlie the improvement of most cancers. Certain DNA or RNA markers may also consequently assist in the detection and remedy of particular cancers.



Conflict of Interest

The author’s declared that they have no conflict of interest.

Citation: Tripathi A (2022) Biomarkers are Measurable and No Longer Outline how a Man or Woman Feels or Functions. Biomark J. 8:145.

Copyright: © 2022 Tripathi A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.